Search Results
May 07, 2026, 09:05 ET UWorld Supports 93 Future Medical Researchers in Partnership with Goldwater Foundation
developing a mouse model for a genetic disorder and studying mitochondrial function in auditory cells. He has performed laboratory techniques, including RNA analysis and quantitative polymerase chain reaction. He is a varsity cross-country athlete and participates in multiple student organizations.
More news about: UWorld, LLC
May 07, 2026, 07:45 ET Advaita Bio Launches iSCanGuide™: Unified Single-Cell and Spatial Transcriptomics Analysis, Powered by GPU-Accelerated Infrastructure
(Standard/HD) and Xenium. Visualize spatial cell distributions and identify spatially variable genes — all within the same environment used for single-cell RNA-seq, with no data export required.Integrated Frameworks: Feeds directly into iPathwayGuide™ proprietary Impact Analysis methodology for
More news about: Advaita Bio
May 07, 2026, 07:45 ET Advaita Bio Launches iSCanGuide™: Unified Single-Cell and Spatial Transcriptomics Analysis, Powered by GPU-Accelerated Infrastructure
(Standard/HD) and Xenium. Visualize spatial cell distributions and identify spatially variable genes — all within the same environment used for single-cell RNA-seq, with no data export required.Integrated Frameworks: Feeds directly into iPathwayGuide™ proprietary Impact Analysis methodology for
More news about: Advaita Bio
May 07, 2026, 07:00 ET Insmed Reports First-Quarter 2026 Financial Results and Provides Business Update
approved for any indication in any jurisdiction.About INS1202INS1202 is an investigational adeno-associated virus (AAV9) short hairpin RNA (shRNA) construct targeting the human superoxide dismutase type 1 (SOD1) gene. Insmed is developing INS1202 as a potential treatment for patients with
More news about: Insmed Incorporated
May 06, 2026, 22:49 ET Delphi Diagnostics Announces New Publication in the European Journal of Cancer
measures endocrine activity in a breast tumor, and for prognostic use, the Index Score is adjusted for baseline prognosis using molecular subtype genes (RNA4) and clinical factors such as tumor size and regional lymph node involvement. The EAI test has been shown in various studies to be a consistent prognostic
More news about: Delphi Diagnostics Inc
May 06, 2026, 17:11 ET /C O R R E C T I O N -- Mana.bio/
LNP design in early development, a critical bottleneck to advancing RNA therapeutics. In addition, Mana.bio has developed a predictive safety model that helps de-risk LNP design in early development, a critical bottleneck to advancing RNA therapeutics. Mana.bio was founded in Tel Aviv, Israel, and is backed
More news about: Mana.bio
May 06, 2026, 16:30 ET Insmed and Ty Pennington Team Up to Drive Awareness and Proper Diagnosis of Bronchiectasis
early-stage programs encompass a wide range of technologies and modalities, including gene therapy, AI-driven protein engineering, protein manufacturing, RNA end-joining, and synthetic rescue.Headquartered in Bridgewater, New Jersey, Insmed has offices and research locations throughout the United States,
More news about: Insmed Incorporated
May 06, 2026, 09:29 ET Partner Therapeutics Announces Receipt of FDA Commissioner's National Priority Voucher for BIZENGRI® (Zenocutuzumab-zbco) in NRG1 Fusion-Positive Cholangiocarcinoma
a median progression-free survival of over nine months. These data also highlight the critical role of comprehensive molecular testing, particularly RNA-based comprehensive molecular profiling, in identifying patients who may benefit from emerging targeted approaches."About NRG1+ Cholangiocarcinoma Cholangiocarcinoma
More news about: Partner Therapeutics, Inc.
May 06, 2026, 08:02 ET The Foundation Assar Gabrielsson Prize recipients 2026 awarded
prize in the category of basic science research for centers on understanding how RNA modifications regulate cancer biology, with a particular emphasis on high-risk neuroblastoma. These findings contribute to understanding RNA-mediated mechanisms underlying tumor cell identity in aggressive neuroblastoma,"
More news about: AB Volvo
May 06, 2026, 07:00 ET (E,E)-bisantrene Discovered to Function via Silencing of c-MYC Expression
by Racura and collaborators identified that (E,E)-bisantrene exerts its anticancer activity by binding to and stabilizing G-quadruplex (G4) DNA and RNA structures, key regulatory elements involved in controlling oncogene expression.At the American Association for Cancer Research (AACR) Annual
More news about: Racura Oncology
May 05, 2026, 16:15 ET Factor Bioscience to Deliver Seven Presentations at the American Society of Gene & Cell Therapy (ASGCT) 29th Annual Meeting
programs-Presentations will include latest data from Factor's IL12-expressing iMacrophages for treating solid tumors (FACT-112), as well as recent advances in Factor's RNA-based cell reprogramming technologies-Factor to reveal two novel iPSC-derived mesenchymal stem cell (iMSC) programs: Hypoimmune iMSCs for muscular
More news about: Factor Bioscience
May 05, 2026, 15:12 ET Molecular Instruments & Empire Genomics Launch NISH Powered by HCR™ Pro: The Largest Ready-to-Use, Fully Automated ISH Library, Exclusively Available Worldwide on NeoPATH Pro
built on HCR™ Pro RNA-ISH, a protease-free approach to RNA in situ hybridization in FFPE tissue. By avoiding protease digestion, the workflow is designed to support tissue morphology and protein target integrity. HCR™ HiFi Probes are engineered for background suppression and enable RNA-and-protein co-detection
More news about: Empire Genomics
May 05, 2026, 09:07 ET CapyBio Launches Cell Identity Services to Diagnose Differentiation Failure and Improve Engineered Cells
artifacts that can mislead drug discovery and mask true biological signals. A portfolio of optional add-on services is also available, including single-cell RNA sequencing — the data foundation for the Capybara platform. Custom options are available for programs with unique experimental designs."For
More news about: CapyBio
May 05, 2026, 07:30 ET PackGene to Present Advances in Scalable AAV Manufacturing, Analytical Innovation, and Novel Capsid Engineering at ASGCT 2026
to publication)Time: May 14th, 5-6:30 p.m.Title: A Fast Extraction-Free RT-qPCR Assay Utilizing Dual DNA/RNA Targeting for Rapid Mycoplasma Detection in CGT Products (#3215)Time: May 14th, 5-6:30 p.m.Title: Establishment
More news about: Packgene
May 05, 2026, 03:40 ET Senhwa Biosciences Launches Global Study, Targeting Breakthrough in Hard-to-Treat Cancers with CX-5461 and Tislelizumab Combination
and build sustainable long-term growth momentum.CX-5461 features a differentiated dual mechanism of action. In addition to inhibiting ribosomal RNA synthesis and suppressing tumor cell proliferation, it stabilizes G-quadruplex structures, inducing DNA damage and activating the cGAS–STING pathway.
More news about: Senhwa Biosciences, Inc.
May 04, 2026, 07:00 ET Ascidian Completes Dose Escalation Portion of Phase 1/2 STELLAR Trial of ACDN-01 for Stargardt Disease and Announces Expanded Clinical Study Plans
affected gene.About Ascidian TherapeuticsAscidian Therapeutics is redefining the treatment of disease by rewriting RNA. By editing exons at the RNA level, Ascidian therapies enable precise post-transcriptional editing of genes, resulting in full-length, functional proteins at the right
More news about: Ascidian Therapeutics
May 04, 2026, 07:00 ET Insmed to Present Data Across Its Respiratory Portfolio, Including Late-Breaking ARIKAYCE® Results from Phase 3b ENCORE Study, at the American Thoracic Society International Conference 2026
early-stage programs encompass a wide range of technologies and modalities, including gene therapy, AI-driven protein engineering, protein manufacturing, RNA end-joining, and synthetic rescue.Headquartered in Bridgewater, New Jersey, Insmed has offices and research locations throughout the United States, Europe,
More news about: Insmed Incorporated
May 01, 2026, 08:37 ET Researchers from Incheon National University Spotlight Next-Generation EV Diagnostics
biopsies worldwide. Extracellular vesicles, or EVs, are tiny membrane-bound particles released by nearly all cells. They carry proteins, RNA, lipids, and other biological cargo that reflect the condition of their parent cells. Because EVs circulate in blood, urine, and other body fluids, scientists
More news about: Incheon National University
Apr 30, 2026, 17:44 ET Rosalind Franklin University Helix 51 Incubator Company BLR Bio Presents Promising New Scleroderma Drug Data at International Rheumatology Meeting
further elucidate both the mechanism of action and efficacy of BLR-200 in a bleomycin-induced in vivo model of systemic sclerosis. Using single-cell RNA sequencing and UMAP analysis of total skin fibroblasts — cells with the potential to drive scarring — bleomycin induced a unique population expressing
More news about: Rosalind Franklin University of Medicine and Science
Apr 30, 2026, 09:00 ET Co-Diagnostics Announces First Quarter 2026 Earnings Release Date and Webcast
technologies. The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR at-home and point-of-care platform (subject to regulatory
More news about: Co-Diagnostics
Apr 30, 2026, 09:00 ET Astellas to Highlight New Findings for Geographic Atrophy at ARVO 2026 Annual Meeting
Population pharmacokinetics profile of avacincaptad pegol, a pegylated RNA aptamer approved for the treatment of GA secondary to AMD
More news about: Astellas Pharma Inc.
Apr 30, 2026, 07:00 ET Insmed to Present at May 2026 Investor Conferences
early-stage programs encompass a wide range of technologies and modalities, including gene therapy, AI-driven protein engineering, protein manufacturing, RNA end-joining, and synthetic rescue.Headquartered in Bridgewater, New Jersey, Insmed has offices and research locations throughout the United States, Europe,
More news about: Insmed Incorporated
Apr 29, 2026, 10:15 ET /C O R R E C T I O N -- Bio-IT World Conference & Expo/
AI-driven Structure-enabled Antiviral Platform (ASAP) is an open-science consortium developing oral, clinic-ready therapeutics for pandemic-potential RNA viruses. Funded by NIAID investment, ASAP leverages the cost-efficient COVID Moonshot model to bridge the "preclinical valley of death." By integrating
More news about: Bio-IT World Conference & Expo
Apr 29, 2026, 09:00 ET Circular Genomics and Vitazi.ai Forge Strategic Alliance to Develop First-in-Class Multimodal Workflow for Early Alzheimer's Detection
Analytical Framework Combines AI-Powered Retinal Imaging with Proprietary Circular RNA Biomarkers to Unlock Scalable, Non-Invasive Pathway for Early-Stage Alzheimer's Identification SAN DIEGO, April 29, 2026
More news about: Circular Genomics
Apr 29, 2026, 08:56 ET NanoMosaic to Showcase the FDA/CBER AMT Designated Analytics Platform at ASGCT 2026
quantificationDate/Time: 5/14/2026, 5:00PM-6:30PMNanoMosaic Poster 1 launching the RNA quantification assay on Tessie system: Poster No. 3222Title: Integrated AAV genome integrity and transgene RNA quantification using a single nanoneedle-based platformDate/Time: 5/14/2026,
More news about: NanoMosaic